feed,title,long_url,short_url
BioRxiv,Neutralization of Mu and C.1.2 SARS-CoV-2 Variants by Vaccine-elicited Antibodies in Individuals With and Without Previous History of Infection,https://biorxiv.org/cgi/content/short/2021.10.19.463727v1?rss=1,https://j.mp/3E60VGN
BioRxiv,Preparation of ingestible antibodies to neutralize the binding of SarsCoV2 RBD (receptor binding domain) to human ACE2 Receptor,https://biorxiv.org/cgi/content/short/2021.10.19.464951v1?rss=1,https://j.mp/3nh5kQp
BioRxiv,"Oral Lisinopril Raises Tissue Levels of ACE2, the SARS-CoV-2 Receptor, in Healthy Male and Female Mice",https://biorxiv.org/cgi/content/short/2021.10.19.465025v1?rss=1,https://j.mp/3nbDHIm
BioRxiv,Repurposed nystatin to inhibit SARS-CoV-2 and mutants in the GI tract,https://biorxiv.org/cgi/content/short/2021.10.19.464931v1?rss=1,https://j.mp/3jnA693
